Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00582_DB01201_nanopub.RApyuZ-xDMgQpy9Fv-2FbMg1qzLdqRGuai1I3GfKkBG7M#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00582_DB01201 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00582_DB01201 label "DDI between Voriconazole and Rifapentine - Rifapentine may decrease the serum concentration of voriconazole likely by increasing its metabolism via CYP3A enzymes. Voriconazole may increase the serum concentration of rifapentin likely by inhibiting its metabolism via CYP3A. Concomitant therapy is contraindicated. [drugbank_resource:DB00582_DB01201]" assertion.
- drugbank_resource:DB00582_DB01201 identifier "drugbank_resource:DB00582_DB01201" assertion.
- drugbank_resource:DB00582_DB01201 title "DDI between Voriconazole and Rifapentine - Rifapentine may decrease the serum concentration of voriconazole likely by increasing its metabolism via CYP3A enzymes. Voriconazole may increase the serum concentration of rifapentin likely by inhibiting its metabolism via CYP3A. Concomitant therapy is contraindicated." assertion.
- drugbank:DB00582 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00582_DB01201 assertion.
- drugbank:DB01201 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00582_DB01201 assertion.